Amesite enters $-capped at-the-market share sale deal with H.C. Wainwright
On July 17, 2026, Amesite entered an At The Market Offering Agreement with H.C. Wainwright & Co. under which it may sell common stock through the agent from time to time, up to a maximum amount defined in the agreement. The filing says the company is not obligated to sell any shares, and that proceeds, if any, would go to general corporate and working capital purposes; sales would dilute existing shareholders, though the filing does not quantify the share count or total proceeds.
Key points
- Agreement dated July 17, 2026, with H.C. Wainwright & Co., LLC as sales agent
- Agent commission of 3.0% of gross proceeds from each share sale, plus legal fee reimbursement capped at $50,000
- Shares to be sold under a Form S-3 shelf registration (File No. 333-282999) effective December 18, 2024
- No obligation to sell any shares; the filing gives no amount or timing for sales
The filing
Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 20, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.